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Abstract
Background: In 2012, the United Kingdom (UK) Government announced that the new entrant screening for active
tuberculosis (TB) in Heathrow and Gatwick airports would end. Our study objective was to estimate screening yield
and diagnostic accuracy, and identify those at risk of active TB after entry.
Methods: We designed a retrospective cohort study and linked new entrants screened from June 2009 to September
2010 through probabilistic matching with UK Enhanced TB Surveillance (ETS) data (June 2009 to December 2010). Yield
was the proportion of cases reported to ETS within three months of airport screening in the screened population. To
estimate screening diagnostic accuracy we assessed sensitivity, specificity, positive and negative predictive values.
Through Poisson regression we identified groups at increased risk of TB diagnosis after entry.
Results: We identified 200,199 screened entrants, of these 59 had suspected TB at screening and were reported within
3 months to ETS (yield = 0.03 %). Sensitivity was 26 %; specificity was 99.7 %; positive predictive value was 13.2 %;
negative predictive value was 99.9 %. Overall, 350 entrants were reported in ETS. Persons from countries with annual TB
incidence higher than 150 cases per 100,000 population and refugees and asylum seekers were at increased risk of TB
diagnosis after entry (population attributable risk 77 and 3 % respectively).
Conclusion: Airport screening has very low screening yields, sensitivity and positive predictive value. New entrants
coming from countries with annual TB incidence higher than 150 per 100,000 population, refugees and asylum seekers
should be prioritised at pre- or post-entry screening.
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Background
The incidence of tuberculosis (TB) in the United Kingdom
(UK) increased between 1990 and 2005, stabilized until
2011 and decreased in the three following years. In 2014,
6622 cases of TB were reported in England – an incidence
of 12.0 cases per 100,000 population [1–3]. In 2010, 73 %
of newly diagnosed TB cases with a known country of
birth were born outside the UK; TB incidence among
these was 81.6 per 100,000 population, around 20 times
higher than those born in the UK (3.9 per 100,000 popula-
tion). Most of these cases were born in South Asia (55 %)
or Sub-Saharan Africa (26 %); regions with the highest
incidence of TB disease in the world [4]. The majority of
cases born out of the UK (77 %) were diagnosed two or
more years after entering the UK [5].
In response to increasing migration to the UK of
individuals born in TB high risk countries, the UK
government set up new entrant screening for active TB at
ports of entry (“new entrants screening”) in 1965 [6]. Chest
x-rays were introduced at London Heathrow airport for
long-stay new entrants. Screening was subsequently ex-
tended to London Gatwick airport. The aim of screening
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was to reduce importation of TB into the UK at entry by
identifying active pulmonary disease among those who were
seeking to remain in the UK for longer than six months so
as to prevent onward transmission [7]. Those making
shorter visits to the UK were not routinely screened for TB.
Different studies on cohorts of new entrants and
reviews of screening practices have concluded that the
new entrants screening programme in the UK was an in-
effective and inefficient method for detecting active
cases of TB [8–12]. While they provided a consistent
evaluation over a long period of time, their findings
were limited, they were only undertaken at local level
[8, 9, 11, 12] or did not have a robust study design
by not taking into account TB cases subsequently
diagnosed after entry [10].
The aim of our large population based study, under-
taken in March 2011, was to review the yield and the
outcomes of new entrant screening at Heathrow and
Gatwick to contribute to the advice of the Health
Protection Agency (HPA) to the UK government on the
future of on-entry screening.
In May 2012, there was a UK government announce-
ment that on entry screening would end. It was discontin-
ued in summer 2012 at Gatwick airport and on 31 March
2014 at Heathrow airport [13]. Our study objectives were:
i) to estimate the yield of the screening: i.e. the proportion
of true TB cases among all screened new entrants; ii) to
estimate the screening diagnostic accuracy in terms of
sensitivity, specificity, positive predictive value (PPV) and
negative predictive value (NPV) related to the suspicion of
active TB at screening; iii) to identify the risk factors asso-
ciated with an increased risk of TB diagnosis after entering
the UK.
Methods
According to the UK government protocol guiding the
new entrants screening policy, individuals entering the
UK older than 15 years of age, not pregnant, subject to
immigration control, from a country with an estimated
TB incidence greater than 40 per 100,000 (UK definition
of high incidence country[14]) and intending to remain
in the UK for longer than 6 months were referred by UK
Borders Agency staff to the airports’ Health Control
Units (HCU) for screening [7, 10]. New entrants referred
to the HCU underwent a medical assessment for TB,
which could include a chest x-ray. Those suspected of
having active TB were invited to arrange urgent follow
up and register with the medical services close to their
intended residence. The HCU also sent notification of
the new entrants suspected of active TB to the National
Health System (NHS) including the address of the
entrant for follow up. All new entrants not suspected of
having active TB at the time of entry were also invited to
register with a general practitioner for follow up, mainly
for checking BCG vaccination status and possibly
arranging for latent TB screening if relevant.
To achieve the study objectives we designed a retro-
spective cohort study including all new entrants screened
at Heathrow and Gatwick airports from 10 June 2009 to
30 September 2010. Information collected for new
entrants included demographic (name, date of birth and
sex), date and visa of entry, nationality and address in the
UK declared at entry. Identification of those new entrants
who had a TB diagnosis at any point after entry was
determined by matching the cohort of new entrants with
notifications of TB diagnosis from the Enhanced Tubercu-
losis Surveillance database (ETS) from 1 June 2009 to 31
December 2010. ETS is the surveillance system reporting
active TB cases notified by TB clinics in the UK [15]. We
matched the two datasets using a probabilistic algorithm
on the basis of available personal identifiers (name,
surname, sex, date of birth, nationality, address) [16].
We defined: i) a TB suspect as any new entrant
suspected of active TB at screening; ii) a TB diagnosis as
any new entrant who was later notified in ETS with TB;
iii) a TB diagnosis attributable to screening as any new
entrant suspected of TB at screening, later notified in
ETS within 90 days from screening.
We defined the yield of TB attributable to the screening
as the proportion of new entrants suspected and
diagnosed with TB within 90 days after screening among
all screened new entrants during the study period. We
defined 90 days as the necessary maximum time for a new
entrant to follow the indication received at screening,
including the time allowed to come into contact with
the NHS.
In order to assess the screening diagnostic accuracy re-
lated to the suspicion of active TB at screening, we used
ETS as the gold standard. We calculated sensitivity as
the proportion of new entrants suspected of TB among
those diagnosed with TB; specificity as the proportion of
new entrants not suspected of TB among those not diag-
nosed with TB; PPV as the proportion of new entrants
diagnosed with TB among those suspected of TB; NPV
as the proportion of new entrants not diagnosed with
TB among those not suspected of TB.
Finally, we used Poisson regression to identify the
groups of new entrants at increased risk of TB diagnosis
after screening. We considered as cases all individuals
diagnosed with TB at any time within the follow up
period after entry to UK. We took into account age, sex,
type of visa they had been issued and TB incidence in
the country of origin. We categorised study participants
into: i) four age groups (16–24 years, 25–29 years,
30–54 years and 55 years or older); ii) male and female
sex; iii) four visa categories (student, work permit, long
stay visitor and refugee or asylum seekers); iv) country of
origin, grouping countries on the basis of their TB
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incidence in four groups (TB incidence 40–150, including
China, Russia and several central and south American
countries; TB incidence 151–250, including India, Pakistan,
Indonesia and Bangladesh; TB incidence 251–350, in-
cluding Nigeria and several sub-Saharan countries; TB
incidence >350, including South Africa and several
other sub-Saharan countries). Participants’ missing in-
formation were excluded from the analysis. Subse-
quently identifying the groups at increased risk of TB
diagnosis after screening, we also estimated their
population attributable risk (PAR), calculating the
proportion of TB cases explained by these groups
among the overall number of TB cases detected in
our cohort.
Results
We had a total of 200,199 new entrants in our cohort,
57 % were male and over 75 % were younger than
30 years old (median age 25 years, IQR 22–29 years).
New entrants into the UK with student visa were 69.2 %.
Most new entrants were coming from countries with a TB
incidence between 150 and 250 per 100,000 population
(Table 1).
Figure 1 shows the distribution of new entrants based
on the suspicion of TB at entry and on subsequent TB
diagnosis (those identified in ETS). Of the 200,199 new
entrants screened, 678 (0.34 %) were suspected of having
TB at entry. Of these 90 (0.04 %) were later notified in
ETS with TB, of which 59 were diagnosed within 90 days
after screening. Therefore 59 entrants, representing
0.03 % of the total cohort screened, had a TB diagnosis
we attributed to the screening process.
The screening test sensitivity (Table 2) was 25.7 %
(90/350); specificity was 99.7 % (199 261/199849); PPV
was 13.3 % (90/678) and NPV 99.9 % (199261/199521).
A total of 350 new entrants (0.17 %) were diagnosed
with TB at any time within the follow up period after
entry to the UK (Table 3). Taking into account sex, age,
type of visa and country of provenance, we did not find
any association between sex or age and TB diagnosis.
Refugees and asylum seekers were found to have
about 4 times increased risk (adjusted risk ratio ARR
4.27, p <0.01) of TB diagnosis after entry when com-
pared to students. Any new entrant from a country
with a TB incidence ≥150 was approximately 5 to 6
times more at risk of TB diagnosis than those coming
from countries with a TB incidence between 40 and
150 (ARR > 4.93; p <0.01). Finally, in our cohort the
PAR of entering into the UK as an asylum seeker or
a refugee was 0.03 and the PAR of coming from a
country with a TB incidence ≥150 was 0.77; thus re-
spectively three per cent and 77 % of the cases in our
cohort could be explained by these characteristics.
Discussion
In a large study of over 200,000 new entrants to the UK
we found a very low yield of TB, with only 59 TB diag-
noses attributable to the screening in a time period of
15 months. In order to put this figure in context, about
8500 new cases of TB were notified in 2010 in the UK
and 80 % of these were born out of the UK [5]. In
addition, chest X-rays are able to detect mainly pulmon-
ary TB; in 2010, 54 % of the TB diagnoses reported in
individuals born out of the UK were extra-pulmonary
[5]. This is a serious limitation as chest X-rays will not
detect extra-pulmonary TB. Furthermore, the new
entrants screening was performed only in Heathrow and
Gatwick airports and in no other UK port of entries. In
2009 and 2010, likewise in 2016, only a proportion of
new entrants to the UK entered through these two
airports; in fact a growing proportion of new entrants to
the UK enter through other international airports,
maritime ports and railways connecting the UK with
continental Europe. In a 2009 systematic review of the
different new entrant TB screenings in the European
Economic Area and Switzerland, Klinkenberg et al.
Table 1 Short title: main characteristics of new entrants
screened in Heathrow and Gatwick, UK, 2009/2010. Detailed
title: distribution of new entrants on the basis of demographic
characteristics, visa of entry and tuberculosis (TB) incidence in
the country of origin
No. (%)
Sex
Male 114 191 (57.0)
Age (years)
16–24 87 222 (43.6)
25–29 68 762 (34.4)
30–54 41 501 (20.7)
≥55 2 678 (1.3)
Unknown 36 (0.0)
Visa of entry
Student 138 466 (69.2)
Work permit 32 006 (16.0)
Long Stay Visitor 6 321 (3.2)
Refugee/Asylum Seeker 1 913 (1.0)
Unknown 21 493 (10.7)
Incidence of TB in country of origin (annual cases per 100 000)
40–149 57 541 (28.7)
150–249 106 686 (53.3)
250–349 22 001 (11.0)
≥350 5 288 (2.6)
Unknown 8 683 (4.3)
Total 200 199 (100.0)
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identified three different screening strategies: at port of
entry, just after arrival in reception centres and post-
entry at community level. The median yield of these
strategies was about 10 times higher than the UK’s new
entrant screening; screening at reception centres had the
highest yields [17]. In the same review, yields for screen-
ing programs in reception centres and post-entry at
community level in Australia, Canada, Japan and U.S.A.
were also assessed: the highest median yield, 40 times
higher than the UK’s new entrant screening, was
obtained in pre-entry screening. No information was
available on screening at entry ports for these countries
[17]. Zenner et al. in a 2013 primary cost effectiveness
study identified comparable yields among each screening
strategy with at entry screening still not found to be
cost-effective and having little impact on overall TB
trends [18]. In 2009 and 2014 in the USA, Liu et al. and
Posey et al., evaluating pre-entry (overseas) screening,
identified yields substantially higher than in the UK new
entrants screening [19, 20].
The diagnostic accuracy analysis showed screening
had very poor sensitivity. On the other hand, specificity
was nearly 100 %. Due to the very high prevalence of
new entrants without active TB at entry PPV was very
low and NPV almost 100 %.
When we looked at the groups of new entrants at in-
creased risk of TB diagnosis at any follow up point after
screening, we found refugees and asylum seekers having
the highest risk compared to the other VISA categories
of entrants. In this analysis, students were selected as
the comparison group because they were the most
numerous group and those with the lowest risk of TB.
When compared with any other visa category, refugees
and asylum seekers were always found to be at increased
risk. Due to the low number of refugees or asylum
seekers entering in the UK in 2009 and 2010, only three
per cent of the cases in our cohort were in this group.
However, these findings are of increasing interest as the
proportion of refugees and asylum seekers has steeply
grown in recent years in the UK comprising an esti-
mated 8 % of net migration in 2013, comparing with an
estimated 4 % in 2010 [21]. The number of refugees and
asylum seekers to the UK has further increased in 2015.
This finding is even more important at European Union
level, where first time applicant asylum seekers reached
the number of 1,255,640 in 2015 [22].
We also found that new entrants from a country with
a TB incidence higher than 150 per 100,000 population
were at an increased risk of TB diagnosis when
compared with new entrants from countries with a TB
incidence lower than 150 per 100,000. The analysis of
the PAR for this group highlighted that more than 75 %
of the cases in our cohort came from a country with an
incidence ≥150 per 100,000. In these analyses we used
Poisson regression to estimate the risk. Using logistic
regression we obtained very similar estimate of odds
(data not shown). A number of recent studies found that
screening for latent TB among new entrants from coun-
tries with a TB incidence greater than 150 per 100,000 is
the most cost-effective strategy to identify latent TB
[23–25]. This threshold makes an important difference,
since those countries with a TB incidence between 150
and 250 per 100,000 include India, the country contrib-
uting the largest number of new entrants into the UK.
Fig. 1 Short title: Distribution of new entrants on tuberculosis suspicion at entry and tuberculosis diagnosis at community level. Detailed legend:
Distribution of new entrants screened in Heathrow and Gatwick airports on the basis of suspicion of tuberculosis at entry screening in the United
Kingdom and tuberculosis diagnosis at community level through identification in the Enhanced TB Surveillance System (ETS)
Table 2 Short title: distribution of new entrants on tuberculosis
suspicion at entry and diagnosis at community level. Detailed
title: distribution of new entrants on the basis of active
tuberculosis (TB) suspicion identification at entry screening and
tuberculosis diagnosis at community level (identified in the
Enhanced TB Surveillance System (ETS))
TB diagnosis in ETS
Yes No Total
Suspiscion at entry Yes 90 588 678
No 260 199 261 199 521
Total 350 199 849 200 199
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Consistent with this, the 2011 guidelines of the National
Institutes for Health and Clinical Excellence (NICE) for
TB diagnosis and management recommended offering
treatment for latent TB to any new entrant from a coun-
try with a TB incidence greater than 40 per 100,000, ra-
ther than the previous policy of offering TB treatment
only to those new entrants from a country with TB inci-
dence greater than 500 per 100,000, which included
mostly sub-Saharan Africa [26].
Our study results are based on a robust study design
and on a very large sample of individuals. On the other
hand, our study had a number of limitations. The prob-
abilistic matching between the new entrant database and
ETS could have resulted in incomplete or over- match-
ing. However, the accuracy of our probabilistic matching
system is considered high [16], thus we expect the
proportion of mismatched individuals to be very low
and this would underestimate any association identified
in the study. At the time of the matching we had
information only from the TB surveillance systems in
England, Wales and Northern Ireland. Data from
Scotland were not yet available. Therefore we may have
missed a few new entrants who moved to Scotland and
were reported with TB by the Scottish health system.
Since the proportion of TB cases born out of the UK in
Scotland in 2012 was 57 % compared to 74 % in the rest
of the United Kingdom [14], we expect these to be very
few individuals. However, this could have slightly under-
estimated the true screening yield.
Some new entrants may have left the UK before being
diagnosed or may have been missed by ETS. This could
also result in an underestimation of the true screening
yield. Although not perfect, we used ETS as gold stand-
ard in the diagnostic accuracy analysis. Ideally we should
have traced and tested new entrants after screening;
however, due to the very large number of new entrants
screened, this was not practical. Finally, depending on
the time of arrival, and since the ETS data were available
only until the end of 2010, new entrants had a different
probability of being notified in ETS. This was due to the
availability of ETS data when the study was performed
and may have resulted in some TB notifications in ETS
being missed. Therefore the study could have slightly
under-estimated the true screening yield.
The epidemiology of TB in the UK is mainly driven by
reactivation of latent TB acquired before migration
[27, 28]. In 2010, over 75 % TB cases born out of the
UK (77 %) were diagnosed two or more years after enter-
ing the UK; therefore, we would expect several new en-
trants to be diagnosed with TB in the five years following
the end of our study. However, we do not think that the
profile of those diagnosed will change and we expect the
relative risk associated with asylum seeking and refugee
status not to change appreciably.
Table 3 Short title: characteristics of new entrants with tuberculosis and risk factors for tuberculosis diagnosis. Detailed title:
characteristics of new entrants diagnosed with tuberculosis (TB) at any time after entry screening and adjusted risk ratio (ARR), 95 %
confidence interval (95 % CI) and P value for the association between exposure category and TB diagnosis at community level
(identified in the Enhanced TB Surveillance System (ETS))
TB cases (no. = 350) TB cases (%) Adjusted RR 95 % CI P value (Wald test)
Sex
Female 149 (0.17) Ref.
Male 201 (0.18) 0.91 0.70 1.18 0.48
Age (years)
16–24 117 (0.13) Ref.
25–29 134 (0.19) 1.15 0.87 1.52 0.34
30–54 83 (0.20) 1.05 0.73 1.49 0.81
≥55 16 (0.60) 2.36 0.56 9.92 0.24
Visa of entry
Student 197 (0.14) Ref.
Work permit 52 (0.16) 0.78 0.55 1.10 0.16
Long stay visitor 9 (0.14) 0.81 0.40 1.65 0.56
Refugee/Asylum Seeker 10 (0.52) 4.27 2.24 8.13 <0.01
Incidence of TB in country of origin (cases per 100,000 population per year)
40–150 25 (0.04) Ref.
151–250 241 (0.23) 6.14 3.77 10.00 <0.01
251–350 55 (0.25) 4.93 2.40 7.61 <0.01
>350 19 (0.36) 5.53 2.14 14.33 <0.01
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Conclusions
The study provides critical evidence to support the
HPA’s advice and the UK government decision to
discontinue new entrant screening for active tubercu-
losis at Heathrow and Gatwick airports and to opt for
other screening strategies.
New entrants coming from countries with annual TB
incidence over 150 per 100,000 populations, refugees
and asylum seekers should be urgently linked to health
services after arrival in the UK and offered a test for
latent TB; they should also be prioritised in any future
screening. Similar public health actions should also be
implemented in all countries recently affected by the
large movement of people into the European Union [22].
It is also important to repeat the analysis of which
groups in our cohort are at increased risk of TB diagno-
sis after entry with 5 years of follow up to make sure
that the profile of those reported after entry has not
changed.
Finally, screening strategies should be regularly evalu-
ated to make sure that the screening expectations are met
and the screening is operating in the best public health
interest.
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